HAMILTON, Bermuda, Nov. 1, 2016 /PRNewswire/ -- Axovant Sciences Ltd. (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced upcoming presentations at three investor conferences:
- November 8 at 3:30 p.m. MST at the 25th Annual Credit Suisse Healthcare Conference
- November 16 at 1:20 p.m. GMT at the Jefferies 2016 London Healthcare Conference
- November 29 at 12:30 p.m. EST at the 28th Annual Piper Jaffray Healthcare Conference
A simultaneous webcast will be available in the Investors section of Axovant's website at www.axovant.com. A replay will be available for 30 days following each conference.